VERICHEM INTRODUCES LIQUID STABLE REFERENCE MATERIALS FOR AMMONIA TESTING WITH EXTENDED STABILITIES

VERICHEM releases multi-level set of liquid stable and ready-to-use clinical reference materials for the calibration and calibration verification of Ammonia assays with extended shelf-life stability.

Creative Biogene Unveils Comprehensive Services of Bacterial Genome Editing

Creative Biogene unveils its comprehensive services of bacterial genome editing for worldwide pharmaceutical partners after the self-optimization of homologous recombination technology and the CRISPR/Cas9 platform.

Winterlight Labs and Alzheimer Center Amsterdam to decentralize patient assessments in preclinical Alzheimer’s disease research

The Translation team at Francis Crick Institute are working with Cresset Discovery to bring computational chemistry expertise to the Crick

Cambridge, UK – March 29th, 2022 – Cresset Discovery, provider of CADD expertise for drug discovery, is collaborating with the Translation team at The Francis Crick Institute as expert computational chemist in residence.

Absolute Antibody Licenses Novel Fc Silencing Technology from mAbsolve

Easyfairs opens registration for new Connect in Pharma event

Leading international events company Easyfairs has opened online registration for Connect in Pharma, the new event for the European pharma and biopharma community. The first edition of the event, taking place on 14 & 15 September 2022, will create a new vision of the future of pharma and biopharma packaging, devices and production.

Jumpcode Genomics Launches CRISPRclean Single Cell RNA Boost Kit

CRISPRclean® technology improves single cell transcriptional profiling, enabling scientists to discover and see signals that were previously obscured by abundant genomic sequences

Analytical News: T,C&A Lab Offers Insights on Carbon Fiber Testing

Alfa Chemistry’s testing branch - T,C&A Lab, has recently announced to provide carbon fiber testing service for customers worldwide. Experts from Alfa Chemistry will offer insights on a series of tests carried out to characterize carbon fiber performance.

Samsung Biologics holds 11th Annual General Meeting of Shareholders

CTL Amedica Corp Increases International Footprint: Receives Two Product Registration Certifications from Guatemala Ministry of Public Health and Social Assistance

The Guatemala Ministry of Public Health and Social Assistance has certified CTL Amedica Corporation’s registration for two product lines: the VALEO™ II TL Silicon Nitride Interbody Fusion Devices, and the RAPHAEL™ Pedicle Fixation Platform. This certification will enable CTL Amedica to market these products in Guatemala. This is CTL Amedica’s first product registration certification in Central America, and the company says it will continue its efforts to make its technologies more accessible internationally.

Creative Biogene Released One-Stop C. elegans Aging Research Services to Fuel Your Aging Studies

Creative Biogene announced the release of one-stop C. elegans aging research services to accelerate the speed of partners’ aging studies.

Stanley Capital-backed portfolio company DSS acquires MyMeds&Me

Stanley Capital-backed portfolio company DSS acquires MyMeds&Me 04 April 2022, London - Stanley Capital Partners LLP (SCP), the European and US-focused mid-market private equity firm, today announced the acquisition of MyMeds&Me Limited (MMM) by its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS). DSS is a leading global provider of pharmacovigilance services under the brand Bioclinica. The financial terms of the transaction are not being disclosed.

13th Edition of International Conference on Catalysis, Chemical Engineering and Technology

Content 1 Magnus Group is proud and honoured to invite you to its leading congress in catalysis and chemical engineering, “13th Edition of International Conference on Catalysis, Chemical Engineering and Technology” (Catalysis 2022) which is going to be held in a hybrid format at Orlando, Florida, USA and Virtually during October 21-22, 2022.

PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification

New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics

CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

Valo Health Acquires TARA Biosystems Creating First of its Kind Vertically Integrated Cardiovascular Platform

COMPREHENSIVE OFFERING OF LIQUID STABLE BIO-SYNTHETIC REFERENCE MATERIALS FOR URINE CHEMISTRIES NOW AVAILABLE FROM VERICHEM

VERICHEM now offers clinical laboratorians a comprehensive range of liquid stable and ready-to-use biosynthetic clinical reference materials designed for system calibration and calibration verification testing procedures with urine chemistry assays.

CluePoints Continues Impressive Global Growth with Three New Senior Appointments

CluePoints Continues Impressive Global Growth with Three New Senior Appointments The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team King of Prussia, PA – 5th April, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has appointed Catherine Ditzler as VP Marketing while Céline Daubresse joins as VP People, and James Faust is the new VP Business Operations.

WCG Unveils Strategic Alliance Program for CROs

Leading CROs Increase Adoption of WCG's Suite of Solutions Enabling Connectivity to Top Clinical Trial Sites Via Unrivaled Technology and Staffing Solutions Global Program Drives Collaboration to Increase Efficiency and Reduce Burden on Investigative Sites, Accelerating Clinical Trials Sponsored by Pharmaceutical, Biotech and Medical Device Companies

Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market

Seasoned Healthcare Industry Executive Joins Organization to Lead Business Development, Acquisitions, and Expansion into New Markets